| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 172.95× | 172.95× | 142.50× | 80.37× | 326.33× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.22× | 0.22× | 0.32× | 0.36× | 0.26× | ||
| −3.88× | −3.88× | 0.54× | −0.42× | 0.50× | ||
| −1.84× | −1.84× | 0.34× | −0.28× | 0.30× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 326.33 | 80.37 | 142.50 | 172.95 | 172.95 | |
| Asset Turnover | 0.26 | 0.36 | 0.32 | 0.22 | 0.22 | |
| Cash Conversion (CFO/Net Income) | 0.50 | -0.42 | 0.54 | -3.88 | -3.88 | |
| CFO/EBITDA | 0.30 | -0.28 | 0.34 | -1.84 | -1.84 |